Truist Financial Cuts Teladoc Health (NYSE:TDOC) Price Target to $10.00

Teladoc Health (NYSE:TDOC) had its target price decreased by Truist Financial from $15.00 to $10.00 in a research report released on Friday morning, Benzinga reports. Truist Financial currently has a hold rating on the health services provider’s stock.

Several other brokerages have also recently weighed in on TDOC. Barclays lowered their target price on Teladoc Health from $20.00 to $10.00 and set an overweight rating on the stock in a report on Thursday. Needham & Company LLC reiterated a hold rating on shares of Teladoc Health in a report on Thursday. Evercore ISI decreased their price objective on Teladoc Health from $14.00 to $10.00 and set an in-line rating on the stock in a report on Tuesday, July 9th. Stifel Nicolaus decreased their price target on Teladoc Health from $16.00 to $9.00 and set a hold rating on the stock in a research note on Thursday. Finally, Royal Bank of Canada decreased their price target on Teladoc Health from $25.00 to $18.00 and set an outperform rating on the stock in a research note on Friday, April 26th. Fourteen equities research analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. According to data from MarketBeat.com, Teladoc Health presently has an average rating of Hold and an average target price of $14.44.

Teladoc Health Stock Down 3.6 %

Shares of Teladoc Health stock traded down $0.29 during trading on Friday, reaching $7.66. The company’s stock had a trading volume of 5,144,027 shares, compared to its average volume of 5,461,081. The company has a quick ratio of 3.74, a current ratio of 3.82 and a debt-to-equity ratio of 0.67. The company has a market cap of $1.30 billion, a price-to-earnings ratio of -5.64 and a beta of 0.93. Teladoc Health has a 1-year low of $7.31 and a 1-year high of $26.00. The company has a 50-day simple moving average of $9.88 and a two-hundred day simple moving average of $13.61.

Insider Buying and Selling

In related news, Director Karen L. Daniel sold 9,834 shares of the company’s stock in a transaction on Thursday, May 23rd. The shares were sold at an average price of $11.90, for a total transaction of $117,024.60. Following the completion of the sale, the director now directly owns 36,995 shares of the company’s stock, valued at approximately $440,240.50. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. In the last three months, insiders sold 15,388 shares of company stock valued at $178,225. Company insiders own 0.95% of the company’s stock.

Institutional Investors Weigh In On Teladoc Health

A number of institutional investors have recently modified their holdings of the stock. Foundations Investment Advisors LLC boosted its holdings in shares of Teladoc Health by 101.2% in the second quarter. Foundations Investment Advisors LLC now owns 58,934 shares of the health services provider’s stock valued at $576,000 after acquiring an additional 29,646 shares in the last quarter. Rhumbline Advisers boosted its holdings in Teladoc Health by 62.9% during the second quarter. Rhumbline Advisers now owns 276,535 shares of the health services provider’s stock worth $2,704,000 after buying an additional 106,770 shares in the last quarter. AM Squared Ltd bought a new stake in Teladoc Health during the second quarter worth approximately $100,000. nVerses Capital LLC boosted its holdings in Teladoc Health by 1,600.0% during the second quarter. nVerses Capital LLC now owns 11,900 shares of the health services provider’s stock worth $116,000 after buying an additional 11,200 shares in the last quarter. Finally, Mizuho Markets Americas LLC bought a new stake in Teladoc Health during the second quarter worth approximately $3,937,000. Institutional investors and hedge funds own 76.82% of the company’s stock.

Teladoc Health Company Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.